inflammatory lung disease
Showing 1 - 1 of 1
Chronic Granulomatous Disease, Inflammatory Gastrointestinal Disease, Inflammatory Skin Disease Trial run by the NIAID (XELJANZ
Enrolling by invitation
- Chronic Granulomatous Disease
- +3 more
- XELJANZ (tofacitinib)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023